A molecular pathway of neurodegeneration linking α-synuclein to ApoE and Aβ peptides

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073 · see citing works

α-synuclein locus duplication as a cause of familial Parkinson's disease

Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029 · see citing works

Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders

Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,763 · see citing works

Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia

Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623 · see citing works

Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration

Schmued, L. C., & Hopkins, K. J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02513-0 · Cited by 1,218 · see citing works

Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease

Ibáñez, P., Bonnet, A. M., Débarges, B., Lohmann, E., Tison, F., Agid, Y., Dürr, A., Brice, A., & Pollak, P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17104-3 · Cited by 1,042 · see citing works

α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration

Chandra, S. S., Gallardo, G., Fernández‐Chacón, R., Schlüter, O. M., & Südhof, T. C. (2005) · Cell · doi:10.1016/j.cell.2005.09.028 · Cited by 967 · see citing works

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944 · see citing works

Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer’s disease

Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912 · see citing works

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871 · see citing works

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830 · see citing works

Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824 · see citing works

Axon degeneration mechanisms: Commonality amid diversity

Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · see citing works

Essential functions of synapsins I and II in synaptic vesicle regulation

Rosahl, T. W., Spillane, D., Missler, M., Herz, J., Selig, D. K., Wolff, J. R., Hammer, R. E., Malenka, R. C., & Südhof, T. C. (1995) · Nature · doi:10.1038/375488a0 · Cited by 719 · see citing works

Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation

Narhi, L. O., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F. H., Sitney, K. C., Denis, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9843 · Cited by 710 · see citing works

β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607 · see citing works

Expression of apolipoprotein E during nerve degeneration and regeneration.

Ignatius, M. J., Gebicke‐Haerter, P. J., Skene, J. H. P., Schilling, J., Weisgraber, K. H., Mahley, R. W., & Shooter, E. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1125 · Cited by 568 · see citing works

The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy

Spillantini, M. G., & Goedert, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06900.x · Cited by 520 · see citing works

Mutant and Wild Type Human α-Synucleins Assemble into Elongated Filaments with Distinct Morphologies in Vitro

Giasson, B. I., Uryu, K., Trojanowski, J. Q., & Lee, V. M. ‐. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7619 · Cited by 505 · see citing works

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., & Roses, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11183 · Cited by 474 · see citing works

Neuron-Specific Apolipoprotein E4 Proteolysis Is Associated with Increased Tau Phosphorylation in Brains of Transgenic Mice

Brecht, W. J., Harris, F. M., Chang, S., Tesseur, I., Yu, G.-Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4315-03.2004 · Cited by 403 · see citing works

Axonal transport defects: a common theme in neurodegenerative diseases

Roy, S., Zhang, B., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0952-x · Cited by 372 · see citing works

Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease

DeMattos, R. B., O'dell, M. A., Parsadanian, M., Taylor, J. W., Harmony, J. A. K., Bales, K. R., Paul, S. M., Aronow, B. J., & Holtzman, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162228299 · Cited by 359 · see citing works

Human and Murine ApoE Markedly Alters Aβ Metabolism before and after Plaque Formation in a Mouse Model of Alzheimer's Disease

Fagan, A. M., Watson, M., Parsadanian, M., Bales, K. R., Paul, S. M., & Holtzman, D. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0483 · Cited by 290 · see citing works

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of α‐synuclein protein implicated in Parkinson's disease

El‐Agnaf, O. M. A., Jakes, R., Curran, M. D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01419-7 · Cited by 258 · see citing works

Alpha-synuclein and transgenic mouse models

Fernagut, P., & Chesselet, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.001 · Cited by 199 · see citing works

Sept4, a Component of Presynaptic Scaffold and Lewy Bodies, Is Required for the Suppression of α-Synuclein Neurotoxicity

Ihara, M., Yamasaki, N., Hagiwara, A., Tanigaki, A., Kitano, A., Hikawa, R., Tomimoto, H., Noda, M., Takanashi, M., Mori, H., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.019 · Cited by 165 · see citing works

APOE-ε2 allele associated with higher prevalence of sporadic Parkinson disease

Huang, X., Chen, P., & Poole, C. (2004) · Neurology · doi:10.1212/01.wnl.0000130159.28215.6a · Cited by 158 · see citing works

Apolipoprotein E controls the risk and age at onset of Parkinson disease

Li, Y., Hauser, M. A., Scott, W. K., Martin, E. R., Booze, M. W., Qin, X., Walter, J. W., NANCE, M. A., Hubble, J. P., Koller, W. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000128089.53030.ac · Cited by 144 · see citing works

In Vivo Effects of ApoE and Clusterin on Amyloid-β Metabolism and Neuropathology

Holtzman, D. M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:247 · Cited by 138 · see citing works

Ubiquitination of α-Synuclein

Nonaka, T., Iwatsubo, T., & Hasegawa, M. (2004) · Biochemistry · doi:10.1021/bi0485528 · Cited by 137 · see citing works

Aging Increased Amyloid Peptide and Caused Amyloid Plaques in Brain of Old APP/V717I Transgenic Mice by a Different Mechanism than Mutant Presenilin1

Dewachter, I., Dorpe, J. V., Smeijers, L., Gilis, M., Kuipéri, C., Laenen, I., Caluwaerts, N., Moechars, D., Checler, F., Vanderstichele, H., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06452.2000 · Cited by 104 · see citing works

A nontransgenic mouse model shows inducible amyloid-β (Aβ) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade

Dolev, I., & Michaelson, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404458101 · Cited by 102 · see citing works

Proteasome dysfunction in aged human α-synuclein transgenic mice

Chen, L., Thiruchelvam, M. J., Madura, K., & Richfield, E. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.004 · Cited by 88 · see citing works

Causal relation between α synuclein gene duplication and familial Parkinson’s disease

Inserm, U. (2005) · Dkgest of the World Latest Medical Information · Cited by 81 · see citing works

Molecular genetics of Alzheimerʼs disease: the role of β-amyloid and the presenilins

Tandon, A., Rogaeva, E. A., MULLAN, M. J., & George‐Hyslop, P. S. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00003 · Cited by 80 · see citing works

Elevated Aβ and Apolipoprotein E in AβPP Transgenic Mice and Its Relationship to Amyloid Accumulation in Alzheimer’s Disease

Kuo, Y., Crawford, F., MULLAN, M. J., Kokjohn, T. A., Emmerling, M. R., Weller, R. O., & Roher, A. E. (2000) · Molecular Medicine · doi:10.1007/bf03401785 · Cited by 68 · see citing works

Familial Dementia With Lewy Bodies

Tsuang, D. W., Dalan, A. M., Eugenio, C. J., Poorkaj, P., Limprasert, P., Spada, A. R. L., Steinbart, E. J., Bird, T. D., & Leverenz, J. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1622 · Cited by 67 · see citing works

Influence of Apolipoprotein E Genotype on Neuronal Damage and ApoE Immunoreactivity in Human Hippocampus Following Global Ischemia

Horsburgh, K. J., Graham, D. I., Stewart, J., & Nicoll, J. A. R. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199903000-00002 · Cited by 64 · see citing works

Pathological Proteins in Parkinson's Disease: Focus on the Proteasome

Snyder, H. M., & Wolozin, B. L. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:425 · Cited by 59 · see citing works

Observations on the progress of Wallerian degeneration in transected peripheral nerves of C57BL/Wld mice in the presence of recruited macrophages

Hall, S. M. (1993) · Journal of Neurocytology · doi:10.1007/bf01181567 · Cited by 37 · see citing works

Mechanisms and models of α-synuclein-related neurodegeneration

Springer, W., & Kahle, P. J. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-996-0025-8 · Cited by 16 · see citing works

α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

Burré, J., Sharma, M., Tsetsenis, T., Buchman, V. L., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,817 · see citing works

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425 · see citing works

Apolipoprotein E in Alzheimer’s disease and other neurological disorders

Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · see citing works

Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight

Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595 · see citing works

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Compta, Y., Parkkinen, L., O’Sullivan, S. S., Vandrovcová, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 585 · see citing works

A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward

Belloy, M. E., Napolioni, V., & Greicius, M. D. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.056 · Cited by 570 · see citing works

Neuropathologic substrates of Parkinson disease dementia

Irwin, D. J., White, M. T., Toledo, J. B., Xie, S. X., Robinson, J. L., Van Deerlin, V., Lee, V. M. ‐., Leverenz, J. B., Montine, T. J., Duda, J. E., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23659 · Cited by 518 · see citing works

Ageing, neurodegeneration and Parkinson's disease

Hindle, J. V. (2010) · Age and Ageing · doi:10.1093/ageing/afp223 · Cited by 430 · see citing works

α-synuclein in the pathophysiology of Alzheimer’s disease

Twohig, D., & Nielsen, H. M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0320-x · Cited by 374 · see citing works

Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits

Majumder, S., Richardson, A. G., Strong, R., & Oddo, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025416 · Cited by 401 · see citing works

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice

Gu, X., Long, C.-X., Sun, L., Xie, C., Lin, X. Z., & Cai, H. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-12 · Cited by 341 · see citing works

ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias

Martens, Y. A., Zhao, N., Liu, C.-C., Kanekiyo, T., Yang, A. J., Goate, A. M., Holtzman, D. M., & Bu, G. (2022) · Neuron · doi:10.1016/j.neuron.2022.03.004 · Cited by 316 · see citing works

Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease

Taguchi, Y. V., Liu, J., Ruan, J., Pacheco, J., Zhang, X., Abbasi, J., Keutzer, J. M., Mistry, P. K., & Chandra, S. S. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1525-17.2017 · Cited by 244 · see citing works

Molecular mechanisms of α-synuclein neurodegeneration

Waxman, E. A., & Giasson, B. I. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.013 · Cited by 241 · see citing works

APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis

Uddin, M. S., Kabir, M. T., Al Mamun, A., Abdel-Daim, M. M., Barreto, G. E., & Ashraf, G. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1237-z · Cited by 212 · see citing works

Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins

Huynh, T.-P. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075481 · Cited by 210 · see citing works

Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases

Martin, L. J. (2010) · Pharmaceuticals · doi:10.3390/ph3040839 · Cited by 208 · see citing works

Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model

Gan, L., Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3049-12.2012 · Cited by 182 · see citing works

<i>APOE</i> genotype regulates pathology and disease progression in synucleinopathy

Davis, A. A., Inman, C. E., Wargel, Z. M., Dube, U., Freeberg, B. M., Galluppi, A., Haines, J. N., Dhavale, D. D., Miller, R., Choudhury, F. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay3069 · Cited by 177 · see citing works

Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease

Williams, T., Borchelt, D., & Chakrabarty, P. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-0358-9 · Cited by 166 · see citing works

Biology of Mitochondria in Neurodegenerative Diseases

Martin, L. J. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00005-9 · Cited by 162 · see citing works

Synucleins Have Multiple Effects on Presynaptic Architecture

Vargas, K. J., Schrod, N., Davis, T., Fernández‐Busnadiego, R., Taguchi, Y. V., Laugks, U., Lučić, V., & Chandra, S. S. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.023 · Cited by 160 · see citing works

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease

Williams‐Gray, C. H., Goris, A., Saiki, M., Foltynie, T., Compston, D. A. S., Sawcer, S. J., & Barker, R. (2009) · Journal of Neurology · doi:10.1007/s00415-009-0119-8 · Cited by 157 · see citing works

Hippocampal and Cognitive Aging across the Lifespan: A Bioenergetic Shift Precedes and Increased Cholesterol Trafficking Parallels Memory Impairment

Kadish, I., Thibault, O., Blalock, E. M., Chen, K.-C., Gant, J. C., Porter, N. M., & Landfield, P. W. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4599-08.2009 · Cited by 152 · see citing works

Genetic influences on cognitive decline in Parkinson's disease

Morley, J. F., Xie, S. X., Hurtig, H. I., Stern, M. B., Colcher, A., Horn, S. S., Dahodwala, N. A., Duda, J. E., Weintraub, D. A., Chen‐Plotkin, A. S., et al. (2012) · Movement Disorders · doi:10.1002/mds.24946 · Cited by 152 · see citing works

Enteric alpha‐synuclein expression is increased in <scp>P</scp>arkinson's disease but not <scp>A</scp>lzheimer's disease

Gold, A., Turkalp, Z. T., & Munoz, D. G. (2013) · Movement Disorders · doi:10.1002/mds.25298 · Cited by 132 · see citing works

Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's disease

Yan, J., Liu, X.-H., Han, M., Wang, Y., Sun, X., Yu, N., Li, T., Su, B., & Chen, Z.-Y. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.005 · Cited by 125 · see citing works

A critical evaluation of the ubiquitin–proteasome system in Parkinson's disease

Cook, C. N., & Petrucelli, L. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.01.012 · Cited by 112 · see citing works

Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer’s disease

O’Leary, T. P., Robertson, A., Chipman, P., Rafuse, V. F., & Brown, R. E. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.09.009 · Cited by 111 · see citing works

Early involvement of the cerebral cortex in Parkinson's disease: Convergence of multiple metabolic defects

Ferrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 105 · see citing works

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

Shim, K. H., Kang, M. J., Youn, Y. C., An, S. S. A., & Kim, S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01150-0 · Cited by 98 · see citing works

α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment

Korff, A., Liu, C., Ginghina, C., Shi, M., Zhang, J., & Initiative, F. T. A. D. N. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130458 · Cited by 95 · see citing works

Binding of amyloid β peptide to β 2 adrenergic receptor induces PKA‐dependent AMPA receptor hyperactivity

Wang, D., Govindaiah, G., Liu, R., Arcangelis, V. D., Cox, C. L., & Xiang, Y. K. (2010) · The FASEB Journal · doi:10.1096/fj.10-156661 · Cited by 95 · see citing works

Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases

Alagarsamy, J., Jaeschke, A., & Hui, D. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179892 · Cited by 83 · see citing works

Amyloid β Peptide-(1–42) Induces Internalization and Degradation of β2 Adrenergic Receptors in Prefrontal Cortical Neurons

Wang, D., Yuen, E. Y., Zhou, Y., Yan, Z., & Xiang, Y. K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244335 · Cited by 80 · see citing works

Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes

Utter, S., Tamboli, I. Y., Walter, J., Upadhaya, A. R., Birkenmeier, G., Pietrzik, C. U., Ghebremedhin, E., & Thal, D. R. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181836a71 · Cited by 79 · see citing works

Neuronal response in Alzheimer’s and Parkinson’s disease: the effect of toxic proteins on intracellular pathways

Majd, S., Power, J. H. T., & Grantham, H. J. M. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0211-1 · Cited by 76 · see citing works

Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration

Sharma, M., Burré, J., & Südhof, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004028 · Cited by 73 · see citing works

Genetically engineered mouse models of Parkinson's disease

Crabtree, D., & Zhang, J. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.07.019 · Cited by 71 · see citing works

Suppression of astrocytic autophagy by αB-crystallin contributes to α-synuclein inclusion formation

Lu, S., Guo, Y.-S., Liang, P., Zhang, S., Yin, S., Yin, Y., Wang, X., Ding, F., Gu, X., & Zhou, J. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-018-0143-7 · Cited by 70 · see citing works

Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathies

Lue, L., Walker, D. G., Adler, C., Shill, H. A., Tran, H., Akiyama, H., Sue, L., Caviness, J., Sabbagh, M. N., & Beach, T. G. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00585.x · Cited by 65 · see citing works

Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies

Pieri, L., Chafey, P., Gall, M. L., Clary, G., Melki, R., & Redeker, V. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.10.007 · Cited by 64 · see citing works

Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets

Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67 · see citing works

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

Maarouf, C. L., Beach, T. G., Adler, C. H., Shill, H. A., Sabbagh, M. N., WU, T. L., Walker, D. G., Kokjohn, T. A., Roher, A. E., & Arizona PD Consortium (2012) · Neurological Research · doi:10.1179/1743132812y.0000000063 · Cited by 64 · see citing works

The Genetic Basis of Cognitive Impairment and Dementia in Parkinson’s Disease

Collins, L., & Williams‐Gray, C. H. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00089 · Cited by 62 · see citing works

Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids

Zhao, J., Lü, W., Ren, Y., Fu, Y., Martens, Y. A., Shue, F., Davis, M. D., Wang, X., Chen, K., Li, F., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02361-9 · Cited by 60 · see citing works

Hsp110 mitigates α-synuclein pathology in vivo

Taguchi, Y. V., Gorenberg, E. L., Nagy, M., Thrasher, D. R., Fenton, W. A., Volpicelli‐Daley, L. A., Horwich, A. L., & Chandra, S. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903268116 · Cited by 60 · see citing works

Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis

Wilhelmus, M. M. M., Bol, J. G. J. M., van Haastert, E. S., Rozemüller, A. J. M., Bu, G., Drukarch, B., & Hoozemans, J. J. M. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.021 · Cited by 52 · see citing works

Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population

Chung, S. J., Jung, Y., Hong, M., Kim, M. J., You, S., Kim, Y. J., Kim, J., & Song, K. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.022 · Cited by 52 · see citing works

An evaluation of the impact ofMAPT,SNCAandAPOEon the burden of Alzheimer's and Lewy body pathology

Wider, C. W., Ross, O. A., Nishioka, K., Heckman, M. G., Vilariño‐Güell, C., Jasińska‐Myga, B., Erketin-Taner, N., Rademakers, R., Graff‐Radford, N. R., Mash, D. C., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301413 · Cited by 52 · see citing works

Neurodegenerative diseases: exercising towards neurogenesis and neuroregeneration

Ang, E. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00025 · Cited by 51 · see citing works

Apolipoprotein E deficiency exacerbates spinal cord injury in mice: inflammatory response and oxidative stress mediated by NF-κB signaling pathway

Yang, X., Chen, S., Shao, Z., Li, Y., Wu, H., Li, X., Mao, L., Zhou, Z., Bai, L., Mei, X., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00142 · Cited by 52 · see citing works

Age-related decreases in SYN levels associated with increases in MAP-2, apoE, and GFAP levels in the rhesus macaque prefrontal cortex and hippocampus

Haley, G. E., Kohama, S. G., Urbanski, H. F., & Raber, J. (2010) · AGE · doi:10.1007/s11357-010-9137-9 · Cited by 51 · see citing works

Neuronal Expression of Familial Parkinson's Disease A53T α-Synuclein Causes Early Motor Impairment, Reduced Anxiety and Potential Sleep Disturbances in Mice

Rothman, S. M., Griffioen, K. J. S., Vranis, N. M., Ladenheim, B., Cong, W., Cadet, J.-L., Haran, J., Martin, B., & Mattson, M. P. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-120130 · Cited by 49 · see citing works

Value of genetic models in understanding the cause and mechanisms of Parkinson’s disease

Moore, D. J., & Dawson, T. M. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0045-7 · Cited by 50 · see citing works

Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study

Han, Z., Tian, R., Ren, P., Zhou, W., Wang, P., Luo, M., Jin, S., & Jiang, Q. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0721-7 · Cited by 46 · see citing works

Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-synuclein: Feasibility study

Ghochikyan, A., Petrushina, I., Davtyan, H., Hovakimyan, A., Saing, T., Davtyan, A., Cribbs, D. H., & Agadjanyan, M. G. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.028 · Cited by 44 · see citing works

Genetic Mouse Models of Neurodegenerative Diseases

Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 46 · see citing works

Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease

Emamzadeh, F. N., Aojula, H., McHugh, P. C., & Allsop, D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.042 · Cited by 42 · see citing works

Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors

Braun, A. R., Liao, E. E., Horvath, M., Kalra, P., Acosta, K., Young, M. C., Kochen, N. N., Lo, C. H., Brown, R. Z., Evans, M. D., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00195-6 · Cited by 41 · see citing works

L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson’s disease patients

Borah, A., & Mohanakumar, K. P. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.05.008 · Cited by 40 · see citing works

Translational inhibition of α-synuclein by Posiphen normalizes distal colon motility in transgenic Parkinson mice.

Kuo, Y., Nwankwo, E. I., Nussbaum, R. L., Rogers, J. T., & Maccecchini, M. L. (2019) · Europe PMC (PubMed Central) · Cited by 36 · see citing works

Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective

Banerjee, R., Rai, A., Iyer, S., Narwal, S., & Tare, M. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12209 · Cited by 34 · see citing works

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele

Shahid, M., Kim, J., Leaver, K. R., Hendershott, T. R., Zhu, D., Cholerton, B., Henderson, V. W., Tian, L., & Poston, K. L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.023 · Cited by 34 · see citing works

Apolipoprotein E in Cardiovascular Diseases: Novel Aspects of an Old-fashioned Enigma

Liehn, E. A., Ponomariov, V., Diaconu, R., Streață, I., Ioana, M. I., Crespo-Avilan, G. E., Hernández‐Reséndiz, S., & Cabrera-Fuentes, H. A. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.08.008 · Cited by 29 · see citing works

Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis

Martin, L. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100348 · Cited by 32 · see citing works

Effect of Tiantai No.1 (天泰1号) on β-amyloid-induced neurotoxicity and NF-κ B and cAMP responsive element-binding protein

Wu, Z., Huang, A. C. J., de Vellis, J., & Li, Y. (2008) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-008-0286-y · Cited by 31 · see citing works

OMA1 protease eliminates arrested protein import intermediates upon mitochondrial depolarization

Krakowczyk, M., Lenkiewicz, A. M., Sitarz, T., Malińska, D., Borrero-Landazabal, M. A., Mussulini, B. H. M., Linke, V., Szczepankiewicz, A. A., Biazik, J. M., Wydrych, A., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202306051 · Cited by 31 · see citing works

A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression

Ninkina, N. N., Connor‐Robson, N., Ustyugov, A. A., Tarasova, T. V., Shelkovnikova, T. A., & Buchman, V. L. (2015) · Scientific Reports · doi:10.1038/srep16615 · Cited by 29 · see citing works

Modulation of α-synuclein expression in transgenic animals for modelling synucleinopathies — is the juice worth the squeeze?

Buchman, V. L., & Ninkina, N. N. (2008) · Neurotoxicity Research · doi:10.1007/bf03033857 · Cited by 29 · see citing works

GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with α-synuclein

Koob, A. O., Paulino, A., & Masliah, E. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.034 · Cited by 28 · see citing works

Is malfunction of the ubiquitin proteasome system the primary cause of α-synucleinopathies and other chronic human neurodegenerative disease?

Bedford, L., Hay, D., Paine, S., Rezvani, N., Mee, M., Lowe, J. S., & Mayer, R. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.009 · Cited by 28 · see citing works

Association between apolipoprotein E genotypes and Parkinson’s disease

Pulkes, T., Papsing, C., Mahasirimongkol, S., Busabaratana, M., Kulkantrakorn, K., & Tiamkao, S. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.01.028 · Cited by 27 · see citing works

Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases

Loch, R. A., Wang, H., Perálvarez‐Marín, A., Berger, P., Nielsen, H. M., Chroni, A., & Luo, J. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.01.022 · Cited by 25 · see citing works

Actin Aggregations Mark the Sites of Neurite Initiation

Zhang, S.-X., Duan, L., Qian, H., & Yu, X. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0012-2 · Cited by 25 · see citing works

Behavioral Phenotyping of Mouse Models of Neurodegeneration

Dumont, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-328-8_15 · Cited by 25 · see citing works

Hindering of proteinopathy-induced neurodegeneration as a new mechanism of action for neuroprotectors and cognition enhancing compounds

Бачурин, С. О., Ustyugov, A. A., Peters, O. M., Shelkovnikova, T. A., Buchman, V. L., & Ninkina, N. N. (2009) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672909050032 · Cited by 24 · see citing works

Cerebrospinal fluid apolipoprotein E concentration decreases after seizure

Wang, L., Han, Y., Chen, D., Xiao, Z., Xi, Z., Xiao, F., & Wang, X. (2010) · Seizure · doi:10.1016/j.seizure.2009.12.001 · Cited by 23 · see citing works

RGS5 augments astrocyte activation and facilitates neuroinflammation via TNF signaling

Yin, S., Ma, X., Sun, Y., Yin, Y., Long, Y., Zhao, C.-L., Ma, J.-W., Li, S., Yan, H., Li, M., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02884-w · Cited by 23 · see citing works

The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain

Domenger, D., Dea, D., Théroux, L., Moquin, L., Gratton, A. P., & Poirier, J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.031 · Cited by 23 · see citing works

Role of Sporadic Parkinson Disease Associated Mutations A18T and A29S in Enhanced α-Synuclein Fibrillation and Cytotoxicity

Kumar, S., Jangir, D. K., Kumar, R., Kumari, M., Bhavesh, N. S., & Maiti, T. K. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00430 · Cited by 23 · see citing works

Gating deficits in isolation‐reared rats are correlated with alterations in protein expression in nucleus accumbens

Roncada, P., Bortolato, M., Frau, R., Saba, P., Flore, G., Soggiù, A., Pisanu, S., Amoresano, A., Carpentieri, A., & Devoto, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05806.x · Cited by 22 · see citing works

α-Synuclein Decreases the Abundance of Proteasome Subunits and Alters Ubiquitin Conjugates in Yeast

Popova, B., Gałka, D., Häffner, N., Wang, D., Schmitt, K., Valerius, O., Knop, M., & Braus, G. H. (2021) · Cells · doi:10.3390/cells10092229 · Cited by 23 · see citing works

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis

van den Berge, S. A., Kevenaar, J., Sluijs, J., & Hol, E. (2012) · Parkinson's Disease · doi:10.1155/2012/420957 · Cited by 23 · see citing works

Understanding the molecular basis of Parkinson’s disease, identification of biomarkers and routes to therapy

Robinson, P. A. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.40 · Cited by 20 · see citing works

Elevated Hapln2 Expression Contributes to Protein Aggregation and Neurodegeneration in an Animal Model of Parkinson's Disease

Wang, Q., Zhou, Q., Zhang, S., Shao, W., Yin, Y., Li, Y., Hou, J., Zhang, X., Guo, Y.-S., Wang, X., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00197 · Cited by 21 · see citing works

Cytosolic Quality Control of Mitochondrial Protein Precursors—The Early Stages of the Organelle Biogenesis

Lenkiewicz, A. M., Krakowczyk, M., & Brągoszewski, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010007 · Cited by 16 · see citing works

Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review

Liampas, I., Kyriakoulopoulou, P., Siokas, V., Tsiamaki, E., Stamati, P., Kefalopoulou, Z. M., Chroni, E., & Dardiotis, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031795 · Cited by 19 · see citing works

Alzheimer’s disease shares gene expression aberrations with purinergic dysregulation of HPRT deficiency (Lesch–Nyhan disease)

Kang, T. H., & Friedmann, T. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.042 · Cited by 19 · see citing works

The role of α-synuclein in neurodegeneration — An update

Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 19 · see citing works

Apolipoprotein E genotype is related to nitric oxide production in platelets

Marcourakis, T., Bahia, V. S., Kawamoto, E. M., Munhoz, C. D., Gorjão, R., Artes, R., Kok, F., Caramelli, P., Nitríni, R., Curi, R., et al. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1516 · Cited by 19 · see citing works

An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease.

Shakir, T., Coulibaly, A. Y., & Kehoe, P. G. (2013) · Europe PMC (PubMed Central) · Cited by 19 · see citing works

The role of APOE alleles in incident Parkinson’s disease. The Norwegian ParkWest Study

Vefring, H. K., Haugarvoll, K., Tysnes, O., Larsen, J. O., Kurz, M. W., & for the Norwegian ParkWest Study group (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01362.x · Cited by 19 · see citing works

Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson’s Disease

Yadav, S. K., Pandey, A. K., Sarkar, S., Yadav, S., Parmar, D., & Yadav, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02636-y · Cited by 18 · see citing works

α-synuclein increases the cellular level of phospholipase Cβ1

Guo, Y., Rosati, B., & Scarlata, S. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.007 · Cited by 18 · see citing works

Hyperactive glial cells contribute to axonal pathologies in the spinal cord of Npc1 mutant mice

Yan, X., Yang, F., Lukáš, J., Witt, M., Wree, A., Rolfs, A., & Luo, J. (2014) · Glia · doi:10.1002/glia.22659 · Cited by 17 · see citing works

Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease

Jung, J. H., Jeon, S., Baik, K., Lee, Y. H., Chung, S. J., Yoo, H. S., Jeong, S. H., Sohn, Y. H., Lee, P. H., & Ye, B. S. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.004 · Cited by 16 · see citing works

Endogenous Human Proteins Interfering with Amyloid Formation

Gharibyan, A. L., Jayaweera, S. W., Lehmann, M., Anan, I., & Olofsson, A. (2022) · Biomolecules · doi:10.3390/biom12030446 · Cited by 17 · see citing works

Cognitive, Neuropsychiatric, and Motor Features Associated With Apolipoprotein E ∊4 Allele in a Sample of Bulgarian Patients With Late-Onset Parkinson’s Disease

Pavlova, R., Mehrabian, S., Petrova, M., Skelina, S., Mihova, K. Y., Jordanova, A., Mitev, V., & Traykov, L. D. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317514525655 · Cited by 16 · see citing works

Neuroprotective actions of norepinephrine in neurological diseases

Ghasemi, M., & Mehranfard, N. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02999-w · Cited by 15 · see citing works

A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and A beta paptides

Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008) · Max Planck Institute for Plasma Physics

Apolipoprotein E and alpha-synuclein interactions, and their associations with neurodegenerative diseases

Twohig, D. (2021) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and A beta peptides

Gallardo, G., Schlüter, O. M., & Südhof, T. C. (2008) · MPG.PuRe (Max Planck Society)

Effects of different isoforms of apoE on aggregation of the α‐synuclein protein implicated in Parkinson’s disease

Emamzadeh, F. N., Aojula, H., McHugh, P. C., & Allsop, D. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.042 · Cited by 42 · see citing works

Development of New Treatments for Parkinson’s Disease in Transgenic Animal Models: A Role for β-Synuclein

Masliah, E., & Hashimoto, M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00029-3 · Cited by 33 · see citing works